Dr. Reddy's launches generic Taxotere

HYDERABAD, India — Dr. Reddy's Labs on Monday announced the launch of docetaxel injection USP in 20-mg and 80-mg dosage strengths. The drug is the generic version of Taxotere.

 

Taxotere brand and generic had sales in the United States of $218 million for the 12 months ending September 2014, according to IMS Health data. The drug is used to treat various types of cancer. 

 

Dr. Reddy's docetaxel injection USP are available as a single dose, one-vial formula that doesn't require a prior dilution and is ready to add to the intravenous infusion solution, the company stated.